Escape from senescence: molecular basis and therapeutic ramifications
The Journal of Pathology · 2023-08 · 260 (5) · 649-665
DOI: 10.1002/path.6164 ↗At a glance
Übersichtsarbeit in The Journal of Pathology, published online on 2023-08-07. Written by Konstantinos Evangelou and 4 co-authors. Institution: Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National and Kapodistrian University of Athens, Athens, Greec…. Major MEDLINE topics: Cellular Senescence, Neoplasms. Cited 58 times so far (Crossref); 165 references. The full text is freely available (open access, CC BY 4.0). Funded by: European Regional Development Fund, Hellenic Foundation for Research and Innovation, Foundation for Education and European Culture.
Abstract (original language)
Cellular senescence constitutes a stress response mechanism in reaction to a plethora of stimuli. Senescent cells exhibit cell‐cycle arrest and altered function. While cell‐cycle withdrawal has been perceived as permanent, recent evidence in cancer research introduced the so‐called escape‐from‐senescence concept. In particular, under certain conditions, senescent cells may resume proliferation, acquiring highly aggressive features. As such, they have been associated with tumour relapse, rendering senescence less effective in inhibiting cancer progression. Thus, conventional cancer treatments, incapable of eliminating senescence, may benefit if revisited to include senolytic agents. To this end, it is anticipated that the assessment of the senescence burden in everyday clinical material by pathologists will play a crucial role in the near future, laying the foundation for more personalised approaches. Here, we provide an overview of the investigations that introduced the escape‐from‐senescence phenomenon, the identified mechanisms, as well as the major implications for pathology and therapy. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
- Biomedical Research Foundation, Academy of Athens, Athens, Greece.
- Ninewells Hospital and Medical School, University of Dundee, Dundee, UK.
- Faculty Institute for Cancer Sciences, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.
- Center for New Biotechnologies and Precision Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
- Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
ORCID profiles: Konstantinos Evangelou, Konstantinos Belogiannis, Vassilis G Gorgoulis
Funding
- European Regional Development Fund
- Hellenic Foundation for Research and Innovation
- Foundation for Education and European Culture
Cite
APA
Evangelou, K., Belogiannis, K., Papaspyropoulos, A., Petty, R., & Gorgoulis, V. G. (2023). Escape from senescence: molecular basis and therapeutic ramifications. The Journal of Pathology, 260(5), 649-665. https://doi.org/10.1002/path.6164
Vancouver
Evangelou K, Belogiannis K, Papaspyropoulos A, Petty R, Gorgoulis VG. Escape from senescence: molecular basis and therapeutic ramifications. The Journal of Pathology. 2023;260(5):649-665. doi:10.1002/path.6164
BibTeX
@article{Evangelou2023,
author = {Evangelou, Konstantinos and Belogiannis, Konstantinos and Papaspyropoulos, Angelos and Petty, Russell and Gorgoulis, Vassilis G},
title = {Escape from senescence: molecular basis and therapeutic ramifications},
journal = {The Journal of Pathology},
year = {2023},
volume = {260},
number = {5},
pages = {649--665},
doi = {10.1002/path.6164}
}
EUVIMED